| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 1, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received tentative approval from the U.S. Food and Drug Administration for the generic version of Epiduo® Gel (adapalene and benzoyl...
-
Aug 23, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received tentative approval from the U.S. Food and Drug Administration ("FDA") for the generic version of Suprep® (sodium...
-
Aug 17, 2016
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has agreed to acquire Peachtree City, Georgia-based, Geiss, Destin & Dunn, Inc. ("GDD"), a small national distributor of...
-
Aug 10, 2016
Delivered second quarter reported (GAAP) net sales of $1.48 billion and adjusted (non-GAAP) net sales of $1.44 billion, excluding sales of $44 million from held-for-sale businesses* Delivered...
-
Aug 8, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has completed the previously announced divestiture of its U.S. Vitamins, Minerals & Supplements (VMS) business to International...
-
Aug 2, 2016
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.145 per share, payable on September 13, 2016 to shareholders of record on...
-
Jul 27, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter calendar year 2016 on Wednesday, August 10th, 2016 at approximately 6:00 a.m....
-
Jul 20, 2016Appoints John Wesolowski as Acting General Manager, Rx Pharmaceuticals
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE), a leading global provider of Quality Affordable Healthcare Products®, today announced the departure of Douglas Boothe,...
-
Jul 18, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that the U.S. Food and Drug Administration has approved the company's ANDA for omeprazole and sodium bicarbonate capsules, 20mg/1100mg. This...
-
Jun 21, 2016
Perrigo Company plc (NYSE: PRGO; TASE), today announced it has received final U.S. Food and Drug Administration ("FDA") clearance for three milk-based, store brand non-GMO infant formulas....
-
Jun 20, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has reached a definitive agreement to sell its U.S. Vitamins, Minerals & Supplements (VMS) business to International Vitamin...
-
Jun 16, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received final U.S. Food and Drug Administration ("FDA") approval for the generic version of Mallinckrodt Pharmaceuticals' Ofirmev®...
-
Jun 16, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chief Executive Officer John T. Hendrickson will present at the 16th Annual Oppenheimer Consumer Conference at 9:05 AM EDT on...
-
Jun 13, 2016
Perrigo Company plc (NYSE: PRGO; TASE) announced that it has filed Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration (FDA) for ingenol mebutate gel (0.015% and...
-
May 31, 2016
Perrigo Company plc (NYSE: PRGO; TASE) and its partner West-Ward Pharmaceuticals Corp. today announced the U.S. Food and Drug Administration has approved, and that Perrigo has launched,...
-
May 18, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chief Executive Officer John T. Hendrickson will present at the UBS Global Healthcare Conference at 1:30 PM EDT on Tuesday, May...
-
May 16, 2016- No changes to adjusted results or adjusted guidance from original earnings release issued on May 12, 2016
The full corrected release reads as follows: PERRIGO COMPANY PLC REPORTS FIRST QUARTER 2016 FINANCIAL RESULTS Delivered record first quarter adjusted net sales of $1.34 billion excluding VMS sales of
-
May 11, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its first quarter calendar year 2016 on Thursday, May 12, 2016 at approximately 6:00 a.m. (ET)....
-
May 3, 2016
Perrigo Company (NYSE: PRGO; TASE) and its partner Allergan plc (NYSE: AGN) today announced the launch of guaifenesin 1200mg and dextromethorphan HBr 60mg extended-release tablets, the first OTC...
-
May 2, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received final U.S. Food and Drug Administration ("FDA") approval for the generic version of Valeant Pharmaceutical International,...
-
Apr 28, 2016Announces Resignation of Marc Coucke as Executive Vice President and General Manager Branded Consumer Healthcare
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE), a leading global provider of Quality Affordable Healthcare Products®, today announced that Mr. Sharon Kochan, Perrigo's...
-
Apr 26, 2016
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.145 per share, payable on June 14, 2016 to shareholders of record on May 27, 2016.
-
Apr 25, 2016Names Laurie Brlas as Chairman of the Board of Directors
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE), a leading global provider of Quality Affordable Healthcare Products®, today announced the appointment of John T. Hendrickson...
-
Apr 22, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today released the following statement regarding recent media coverage concerning Chairman and CEO Joseph C. Papa: "We are aware of the speculation regarding...
-
Apr 12, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced the first-to-market launch of the over-the-counter (OTC) store brand equivalent to Glucerna® aseptic adult nutritional shake for people with...
-
Mar 23, 2016
Perrigo Company (NYSE: PRGO; TASE) and its partner Allergan plc (NYSE: AGN) today announced the launch of guaifenesin 1200mg extended-release tablets, the OTC store brand equivalent to Mucinex®...
-
Mar 16, 2016
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), showcased eight new product SKUs at the 2016 Global Pet Expo: SENTRY® Vantaguard™ 2 and SENTRY® Flea & Tick Collar...
-
Mar 16, 2016
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), showcased eight new product SKUs at the 2016 Global Pet Expo: PetArmor® Advanced 2 and PetArmor® Flea & Tick Collar...
-
Mar 10, 2016
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the closing of the previously...
-
Mar 10, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman and CEO Joe Papa will present at the Barclays Global Healthcare Conference at 10:15 AM EST on Tuesday, March 15, 2016...
-
Mar 8, 2016
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced the pricing of the previously...
-
Mar 7, 2016
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that Perrigo Finance Unlimited...
-
Mar 1, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman and CEO Joe Papa will present at the Cowen Annual Healthcare Conference at 4:00 PM EST on Monday, March 7, 2016 at the...
-
Feb 23, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman and CEO Joe Papa will present at the RBC Capital Markets Global Healthcare Conference at 8:00 AM EST on Wednesday,...
-
Feb 19, 2016DUBLIN HEADQUARTERS CENTRAL TO EUROPEAN & GLOBAL GROWTH STRATEGY
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE), announced that a number of key public facing corporate functions will be relocated to Ireland as part of the Company's focused international...
-
Feb 18, 2016- Delivered record calendar year 2015 net sales of $5.35 billion, an increase of 28% compared to the prior year; with adjusted net income of $1.09 billion, an increase of 29% compared to the prior year; and adjusted earnings per share of $7.59, an increase of 21% compared to the prior year
Perrigo Company plc (NYSE: PRGO; TASE) today announced results for the fourth quarter and calendar year ended December 31, 2015. Perrigo's Chairman and CEO Joseph C. Papa commented, "The team...
-
Feb 16, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.145 per share, payable on March 15, 2016 to shareholders of record on...
-
Feb 11, 2016
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will announce financial results for its calendar year and fourth quarter 2015 on Thursday, February 18, 2016 at approximately 6:00...
-
Jan 25, 2016- Acquires high barrier-to-entry assets that fit well within Perrigo's unique Rx extended topicals portfolio
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) announced today that it has completed the previously announced acquisition of a portfolio of generic dosage forms and strengths of Retin-A®...
-
Jan 11, 2016
Perrigo Company plc (NYSE: PRGO; TASE) announced today that, following the recent recall of certain dosing cups by its supplier, it has initiated a voluntary product recall in the US to the retail...
-
Jan 11, 2016- Expects full-year 2016 adjusted earnings per diluted share to be in a range of $9.50 to $10.10, an increase of 24% to 29% over 2015 adjusted earnings per diluted share guidance range of $7.65 to $7.85
Perrigo Company plc (NYSE: PRGO; TASE) today increased full-year 2016 adjusted earnings per diluted share guidance to be in a range of $9.50 to $10.10, up from the Company's October 22, 2015...
-
Jan 4, 2016
Allergan plc (NYSE: AGN) and its partner Perrigo Company plc (NYSE: PRGO; TASE) announced the launch of combination guaifenesin 600mg and pseudoephedrine HCl 60mg extended-release tablets to...
-
Dec 29, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman and CEO Joseph Papa will present at the 34th Annual J.P. Morgan Healthcare Conference at 8:00 AM PST on Monday, January...
-
Dec 17, 2015- Acquires unique assets that fit well within Perrigo's Rx extended topicals portfolio
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) announced today that it will acquire a portfolio of generic dosage forms and strengths of Retin-A® (tretinoin) from Matawan Pharmaceuticals,...
-
Nov 23, 2015- Expands Perrigo's Rx extended topicals portfolio to include well-established gastrointestinal product and brand
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) announced today that it will acquire Entocort® (budesonide) capsules as well as the authorized generic capsules marketed by Par Pharmaceuticals...
-
Nov 13, 2015
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) today responded to the news that holders of a majority of its shares rejected Mylan's hostile tender offer, thereby expressing...
-
Nov 10, 2015
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) issued the following response to Mylan's press release. Mylan is resorting to desperate tactics on the eve of its tender offer...
-
Nov 10, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received an AB therapeutic equivalent rating and final U.S. Food and Drug Administration ("FDA") approval for the generic version of...
-
Nov 9, 2015
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) today issued the following shareholder letter: November 9, 2015 CORPORATE GOVERNANCE, MYLAN STYLE: A QUESTION OF TRUST Dear...
-
Nov 9, 2015
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) today responded to misleading statements regarding Marc Coucke, Perrigo Board member as well as Executive Committee member. In...
-
Nov 4, 2015
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on December 15, 2015 to shareholders of record on...
-
Nov 3, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman and CEO Joseph C. Papa will present at the 24th Annual Credit Suisse Healthcare Conference at 1:00 PM MST (3:00 PM EST)...
-
Oct 30, 2015
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today commented on the presentation given by Mylan N.V. ("Mylan") (NASDAQ: MYL) in connection with the announcement of its third quarter 2015...
-
Oct 22, 2015Accelerating Contributions from its Global Operational Platform, Expects to Achieve Operational and Tax Benefits of $175 Million on an Annualized Run Rate Basis
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced it is taking actions to drive substantial profit growth in 2016 and beyond. In total, the actions are expected to add incremental...
-
Oct 22, 2015
Third Quarter Calendar Year 2015* Highlights: Delivered record third quarter net sales of $1.34 billion, comprised of $977 million from consumer-facing businesses Grew net sales by 41%,...
-
Oct 20, 2015
The Bentonville Police Department's K-9 unit will now be protected in the line of duty thanks to the support of PetArmor®, a brand of Perrigo Animal Health, and Walmart. In partnership with...
-
Oct 19, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its third quarter calendar year 2015 on Thursday, October 22, 2015 at approximately 6:00 a.m....
-
Oct 8, 2015
Perrigo Company plc (NYSE: PRGO; TASE), announced today that The Hain Celestial Group, Inc. (Nasdaq: HAIN) through its Earth's Best® brand, has begun to sell organic infant formula in Hong Kong...
-
Oct 5, 2015
Perrigo Company plc (NYSE: PRGO; TASE) and Flamel Technologies (NASDAQ: FLML) announced today that they have entered into an exclusive licensing agreement for LiquiTime® extended release...
-
Sep 22, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received an AB therapeutic equivalent rating and final U.S. Food and Drug Administration ("FDA") approval for the generic version of...
-
Sep 17, 2015Perrigo Positioned to Create Superior Value Through Continued Execution of 'Base Plus Plus Plus' Strategy
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that its Board of Directors has reviewed Mylan's unsolicited tender offer to acquire all of the outstanding shares of Perrigo...
-
Sep 14, 2015Shareholders Advised to Take NO ACTION Pending Review
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today confirmed that Mylan N.V. ("Mylan") (NASDAQ: MYL) has commenced an unsolicited exchange offer to acquire all of the issued and to be issued...
-
Sep 14, 2015
The Atlanta Police Department's K-9 unit will now be protected in the line of duty thanks to the support of PetArmor®, a brand of Perrigo Animal Health, and Walmart. In partnership with Vested...
-
Sep 10, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Morgan Stanley 2015 Global Healthcare Conference at 12:55 PM EDT...
-
Sep 10, 2015
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today responded to Mylan N.V.'s ("Mylan") (NASDAQ: MYL) letter to Perrigo dated September 8th, 2015. Perrigo Chairman, President and CEO Joseph...
-
Sep 2, 2015
The Springfield Police Department's K-9 unit will now be protected in the line of duty thanks to the support of PetArmor®, a brand of Perrigo Animal Health, and Walmart. In partnership with...
-
Aug 31, 2015- Leverages Perrigo's expansive U.S. distribution and customer network to accelerate growth of the brand
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) announced today that it has acquired ScarAway®, a leading U.S. OTC scar management brand, from Enaltus, LLC. The brand is expected to generate...
-
Aug 28, 2015- Exemplifies Perrigo's strategic initiative to further scale the Company's consumer-facing business globally
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that it has completed the acquisition of leading OTC brands from GSK in an all cash transaction valued at €200 million. The...
-
Aug 28, 2015Offer Substantially Undervalues Perrigo, Exposes Shareholders to Risk and Mylan's Weak Business Prospects
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today commented on the Mylan N.V. ("Mylan") (NASDAQ: MYL) shareholder vote regarding its planned unsolicited offer to acquire Perrigo. "Our views...
-
Aug 26, 2015
The St. Louis Police Department's K-9 unit will now be protected in the line of duty thanks to the support of PetArmor®, a brand of Perrigo Animal Health, and Walmart. In partnership with Vested...
-
Aug 14, 2015- "Proposal would incur significant dilution with almost no subsequent leverage to drive an optimal outcome"
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that Institutional Shareholder Services ("ISS"), the leading independent proxy advisory firm, recommended that Mylan NV ("Mylan")...
-
Aug 13, 2015- Would further dilute an already dilutive transaction
Perrigo Company plc ("Perrigo," "the Company") (NYSE: PRGO; TASE) today responded to the announcement that Mylan N.V. ("Mylan") has lowered the acceptance condition for its proposed unsolicited...
-
Aug 12, 2015
Perrigo Company plc (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on September 15, 2015 to shareholders of record on...
-
Aug 11, 2015
The Tampa Police Department's K-9 unit will now be protected in the line of duty thanks to the support of PetArmor®, a brand of Perrigo Animal Health and Walmart. In partnership with Vested...
-
Aug 5, 2015
Second Quarter Calendar Year 2015* Highlights: Delivered record quarter net sales of $1.53 billion, comprised of $1.15 billion from consumer-facing businesses. Compared to the prior year, adjusted...
-
Jul 24, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it will release financial results for its second quarter calendar year 2015 on Wednesday, August 5, 2015 at approximately 8:00 a.m....
-
Jul 22, 2015-- Exemplifies Perrigo's unique brand-building capabilities and impressive distribution network across Europe
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that it has entered into an agreement to acquire Naturwohl Pharma GmbH with its leading German dietary supplement brand, Yokebe....
-
Jun 16, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Executive Vice President and CFO Judy Brown will present at the Oppenheimer 15th Annual Global Consumer Conference at 11:45 AM ET on
-
Jun 2, 2015-- Portfolio includes well-established European brands in the areas of nicotine replacement therapy, cold and flu, and cold sore management
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that it has entered into an agreement to acquire a portfolio of well-established over-the-counter ("OTC") brands from...
-
May 27, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Jefferies 2015 Healthcare Conference at 4:30 PM EDT on Tuesday,...
-
May 12, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 UBS Global Healthcare Conference at 11:30AM EST on Monday,...
-
May 12, 2015-- Further strengthens Perrigo's supply chain capabilities with the addition of softgel manufacturing technology
Perrigo Company plc (NYSE: PRGO; TASE) announced today that it has acquired the Mexican operations of Durham, North Carolina-based Patheon for $34 million in cash. The acquisition is expected to...
-
May 5, 2015
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), today announced that it has launched PetArmor® Joint Health Maximum. PetArmor Joint Health Maximum is a supplement for...
-
Apr 30, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 Deutsche Bank 40th Annual Healthcare Conference at 11:20AM...
-
Apr 29, 2015Offer Remains Below Initial April 8th Proposal Based on Unaffected Mylan Stock Price
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced its rejection of the revised unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL) to acquire all of the outstanding shares of...
-
Apr 28, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Board of Directors declared a quarterly dividend of $0.125 per share, payable on June 16, 2015 to shareholders of record on May 29,...
-
Apr 24, 2015Offer Significantly Below Prior Proposal Based on Unaffected Mylan Stock Price
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO, TASE) today announced its rejection of the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL) to acquire all of the outstanding...
-
Apr 22, 2015
Dublin, Ireland – April 22, 2015 – On April 16, Perrigo Company plc (NYSE: PRGO; TASE) announced it had received final U.S. Food and Drug Administration approval and had launched the...
-
Apr 21, 2015Company Provides Guidance for Calendar Year 2015 and Three-Year Organic Net Sales Growth Rate Goals
Third Quarter FY 2015 Highlights: Delivered record fiscal third quarter net sales of $1.05 billion. Excluding the effect of the pre-closing debt and equity issuances related to the Omega Pharma...
-
Apr 21, 2015This is an announcement falling under Rule 2.4 of Irish Takeover Panel Act, 1997, Takeover Rules, 2013 (the "Irish Takeover Rules").
Perrigo Company plc ("Perrigo") (NYSE: PRGO; TASE) today announced that its Board of Directors has unanimously rejected the unsolicited Proposal (the "Proposal") from Mylan NV ("Mylan") (NASDAQ:...
-
Apr 20, 2015
Thousands of law enforcement K-9s put their lives on the line to protect America on a daily basis. They are usually the first officer to enter a dangerous situation, and help track and neutralize...
-
Apr 16, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final Federal Drug Administration approval for Triamcinolone Acetonide Topical Aerosol, the generic version of Sun...
-
Apr 8, 2015This is an announcement falling under Rule 2.4 of Irish Takeover Panel Act, 1997, Takeover Rules, 2013 (the "Takeover Rules").
Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO; TASE) notes the announcement made by Mylan NV ("Mylan") (NASDAQ: MYL). Perrigo confirms that it has received an unsolicited,...
-
Apr 8, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application for...
-
Mar 30, 2015- Advances Perrigo's stated strategy to expand internationally and leverage the combined product portfolio of Perrigo and Omega
Perrigo Company plc (NYSE: PRGO; TASE), a leading global provider of "Quality Affordable Healthcare Products®," today announced that it has completed the acquisition of Belgian-based Omega Pharma...
-
Mar 4, 2015
Booth No. 2615 -- Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO; TASE), showcased two new product lines at the 2015 Global Pet Expo: SENTRY® Fiproguard® Plus and SENTRY®...
-
Mar 4, 2015Booth No. 2601
Perrigo Animal Health, a division of Perrigo Company plc (NYSE: PRGO); (TASE: PRGO), showcased two new product lines at the 2015 Global Pet Expo: PetArmor® Plus and PetArmor® Soft & Chewy...
-
Mar 4, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 Barclays Global Healthcare Conference at 8:00AM ET on...
-
Feb 17, 2015
Perrigo Company plc (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the 2015 RBC Global Healthcare Conference at 4:35PM EST on Tuesday,...
-
Feb 5, 2015
Fiscal second quarter net sales increased to a second quarter record of $1.07 billion. Excluding the effect of the pre-closing debt and equity issuances related to the previously announced...